Dark
Streaming/Mobile
OldĀ Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
12:41:06 EST Wed 18 Nov 2026
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR+ Search
SEDAR+ Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR+ Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:MRNA
- MODERNA INC -
https://www.modernatx.com/
12:41:06 EST
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
MRNA
- Q
2.5
204.15
·
204.57
1.5
204.325
-2.475
-1.2
3,139.8
628,836
43,080
206.80
208.68
199.20
280.80 22.29
12:23:02
Nov 12
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Up
-- UPC Restricted:
No
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Portfolio
Recent Trades - Last 10 of 43080
More trades...
Time ET
Ex
Price
Change
Volume
12:23:09
Q
204.51
-2.29
2
12:23:08
Q
204.57
-2.23
1
12:23:08
Q
204.4241
-2.3759
1
12:23:07
Q
204.37
-2.43
3
12:23:06
Q
204.33
-2.47
50
12:23:04
Q
204.17
-2.63
4
12:23:04
Q
204.57
-2.23
2
12:23:03
Q
204.325
-2.475
1
12:23:02
Q
204.2188
-2.5812
1
12:23:02
Q
204.37
-2.43
1
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2026-11-12 07:00
U:MRNA
News Release
200
Moderna Outlines Next Phase of Growth at Analyst Day
2026-11-11 11:11
U:MRNA
News Release
200
Moderna Announces JAMA Network Open Publication of Real-World Comparative Effectiveness Data for mNEXSPIKE (COVID-19 Vaccine, mRNA) in Adults Aged 65 Years and Older
2026-11-10 07:00
U:MRNA
News Release
200
Moderna to Present at Upcoming Conference in November 2026
2026-11-06 06:45
U:MRNA
News Release
200
Moderna Reports Third Quarter 2026 Financial Results and Provides Business Updates
2026-11-05 17:21
U:MRNA
News Release
200
Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines
2026-11-04 11:05
U:MRNA
News Release
200
Moderna Advances Investigational Bundibugyo Ebolavirus Vaccine Toward Phase 2/3 Study
2026-11-04 09:55
U:MRNA
News Release
200
Moderna Announces Oral Presentation of mRNA-2808 Clinical Data at 2026 American Society of Hematology Annual Meeting
2026-10-26 09:00
U:MRNA
News Release
200
Immuno-Oncology Emerges as a Major Force in the Global Cancer Treatment Market
2026-10-26 08:53
U:MRNA
News Release
200
A Personalized Cancer Therapy Delivered Positive Phase 3 Results; The Next Race Is Picking Better Targets
2026-10-23 07:00
U:MRNA
News Release
200
Moderna Named a Top Employer by Science for Twelfth Consecutive Year
2026-10-22 14:59
U:MRNA
News Release
200
Merck and Moderna Will Present Results From Landmark Phase 3 INTerpath-001 Trial for Intismeran Autogene Plus KEYTRUDA(TM) (pembrolizumab) at ESMO 2026 Presidential Symposium
2026-10-14 09:45
U:MRNA
News Release
200
AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next Test
2026-10-13 07:00
U:MRNA
News Release
200
Moderna to Report Third Quarter 2026 Financial Results on Friday, November 6, 2026
2026-09-30 07:00
U:MRNA
News Release
200
Moderna Adds Chief Operating Officer Role as Company Expands into Oncology
2026-09-21 10:12
U:MRNA
News Release
200
Moderna Announces Late-Breaking Data to be Presented at ESMO Congress 2026
2026-09-15 09:00
U:MRNA
News Release
200
A $57 Billion Antiviral Market Is Taking Shape As The World Prepares For The Next Viral Threat
2026-09-01 07:00
U:MRNA
News Release
200
Moderna to Present at Upcoming Conferences in September 2026
2026-08-28 07:00
U:MRNA
News Release
200
Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes
2026-08-27 15:57
U:MRNA
News Release
200
Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines
2026-08-27 07:21
U:MRNA
News Release
200
Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes